Prestige Consumer Healthcare
PBH
#3922
Rank
S$4.02 B
Marketcap
S$81.87
Share price
-1.54%
Change (1 day)
-20.06%
Change (1 year)

EPS for Prestige Consumer Healthcare (PBH)

EPS in 2025 (TTM): S$5.36

According to Prestige Consumer Healthcare's latest financial reports the company's current EPS (TTM) is S$5.16. In 2024 the company made an earnings per share (EPS) of S$5.46 an increase over its 2023 EPS that were of S-$2.05.

EPS history for Prestige Consumer Healthcare from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S$5.36-1.94%
2024S$5.46-367.08%
2023S-$2.05-138.33%
2022S$5.3411.7%
2021S$4.7813.6%
2020S$4.21-651.67%
2019S-$0.76-148.78%
2018S$1.56-83.29%
2017S$9.35437.23%
2016S$1.74-34.13%
2015S$2.6452.94%
2014S$1.73-8.11%
2013S$1.88
2011S$1.11

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
S$13.27 157.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Procter & Gamble
PG
S$8.93 73.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$9.35 81.28%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
S$2.19-57.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
S$10.24 98.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Clorox
CLX
S$8.15 57.88%๐Ÿ‡บ๐Ÿ‡ธ USA
CVS Health
CVS
S$0.51-90.15%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$4.57-11.43%๐Ÿ‡ฌ๐Ÿ‡ง UK
Rite Aid
RAD
S-$37.64-829.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Taro Pharmaceutical
TARO
S$1.55-69.95%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel